Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dermatology

  Free Subscription


Articles published in Mycoses

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    February 2023
  1. GALILI E, Goldsmith T, Khanimov I, Arbel C, et al
    Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.
    Mycoses. 2023;66:144-149.
    PubMed     Abstract available


    January 2023
  2. BATVANDI A, Pchelin IM, Kiasat N, Kharazi M, et al
    Time and cost-efficient identification of Trichophyton indotineae.
    Mycoses. 2023;66:75-81.
    PubMed     Abstract available


  3. MOSELEY I, Ragi SD, Ouellette S, Rao B, et al
    Tinea pedis in underrepresented groups: All of Us database analysis.
    Mycoses. 2023;66:29-34.
    PubMed     Abstract available


    December 2022
  4. NYUYKONGE B, Siddig EE, Mhmoud NA, Nyaoke BA, et al
    Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Mycoses. 2022;65:1170-1178.
    PubMed     Abstract available


  5. KHATTAB F, Elkholy BM, Taha M, Abd-Elbaset A, et al
    Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Mycoses. 2022;65:1194-1201.
    PubMed     Abstract available


  6. KOCH C, Nordzieke S, Grieger J, Mayser P, et al
    Medium-chain fatty acid esters are effective even in azole-resistant Malassezia pachydermatis.
    Mycoses. 2022;65:1188-1193.
    PubMed     Abstract available


  7. GUEVARA A, Nery AF, de Souza Carvalho Melhem M, Bonfietti L, et al
    Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Mycoses. 2022;65:1146-1158.
    PubMed     Abstract available


  8. DI VITO M, Scafuro C, Mariotti M, Garzoli S, et al
    Green natural nail polish modified with essential oils to treat onychomycosis.
    Mycoses. 2022;65:1127-1136.
    PubMed     Abstract available


  9. YILMAZ A, Goktay F, Varol R, Gencoglan G, et al
    Deep convolutional neural networks for onychomycosis detection using microscopic images with KOH examination.
    Mycoses. 2022;65:1119-1126.
    PubMed     Abstract available


  10. MUNHOZ LS, Poester VR, Severo CB, Trapaga MR, et al
    Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil.
    Mycoses. 2022;65:1112-1118.
    PubMed     Abstract available


    November 2022
  11. HAGHANI I, Shams-Ghahfarokhi M, Dalimi Asl A, Shokohi T, et al
    Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum-equiseti species complexes from onychomycosis in north of Iran.
    Mycoses. 2022;65:1030-1039.
    PubMed     Abstract available


    October 2022
  12. COGNIALLI R, Bloss K, Weiss I, Caceres DH, et al
    A lateral flow assay for the immunodiagnosis of human cat-transmitted sporotrichosis.
    Mycoses. 2022;65:926-934.
    PubMed     Abstract available


  13. NIODE NJ, Suling PL, Adji A, Miranda E, et al
    Clinico-laboratory findings of Malassezia folliculitis in Indonesia: A multicentre study.
    Mycoses. 2022;65:953-959.
    PubMed     Abstract available


  14. DE OLIVEIRA GV, Maia MLP, Leao FAA, Sad EF, et al
    What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature.
    Mycoses. 2022;65:918-925.
    PubMed     Abstract available


  15. XIA H, Mo XH, Yang LJ, Yang H, et al
    Comparison of samples of blister fluid and scales in the diagnosis of dermatomycosis.
    Mycoses. 2022;65:969-975.
    PubMed     Abstract available


    September 2022
  16. PATEL N, Padhiyar J, Singh R, Bloch A, et al
    Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated dermatophytosis.
    Mycoses. 2022;65:877-886.
    PubMed     Abstract available


    July 2022
  17. POWELL J, Porter E, Field S, O'Connell NH, et al
    Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.
    Mycoses. 2022;65:770-779.
    PubMed     Abstract available


  18. SKAASTRUP KN, Astvad KMT, Arendrup MC, Jemec GBE, et al
    Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
    Mycoses. 2022;65:741-746.
    PubMed     Abstract available


    June 2022
  19. RONG T, Zhu P, Zhou Y, Li Q, et al
    Altered skin fungal and bacterial community compositions in tinea capitis.
    Mycoses. 2022 Jun 11. doi: 10.1111/myc.13480.
    PubMed     Abstract available


  20. EGGER M, Hoenigl M, Thompson GR 3rd, Carvalho A, et al
    Let's talk about sex characteristics-As a risk factor for invasive fungal diseases.
    Mycoses. 2022;65:599-612.
    PubMed     Abstract available


  21. FUHR R, Cook D, Ridden J, Nield K, et al
    Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
    Mycoses. 2022;65:661-669.
    PubMed     Abstract available


  22. NYUYKONGE B, Lim W, van Amelsvoort L, Bonifaz A, et al
    Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Mycoses. 2022;65:650-655.
    PubMed     Abstract available


    May 2022
  23. ZIAKA M, Papakonstantinou E, Vasileiou E, Chorafa E, et al
    Pediatric cutaneous mucormycosis: case report and review of the literature.
    Mycoses. 2022 May 5. doi: 10.1111/myc.13452.
    PubMed     Abstract available


  24. ATSU N, Ergin C, Caf N, Turkoglu Z, et al
    Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples.
    Mycoses. 2022 May 4. doi: 10.1111/myc.13450.
    PubMed     Abstract available


  25. CORREIA NS, Balbinot RTS, Bonacorsi C, Donofrio FC, et al
    Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.
    Mycoses. 2022;65:560-566.
    PubMed     Abstract available


    April 2022
  26. ZHU X, Zheng B, Cai W, Zhang J, et al
    Deep learning-based diagnosis models for onychomycosis in dermoscopy.
    Mycoses. 2022;65:466-472.
    PubMed     Abstract available


  27. NASR M, Abd-Elhamid N, Abd-Allah D, Elkholy B, et al
    Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
    Mycoses. 2022;65:402-410.
    PubMed     Abstract available


  28. SONG G, Zhang M, Liu W, Liang G, et al
    Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020.
    Mycoses. 2022;65:440-448.
    PubMed     Abstract available


  29. BLUME-PEYTAVI U, Tosti A, Falques M, Tamarit ML, et al
    A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Mycoses. 2022;65:392-401.
    PubMed     Abstract available


    March 2022
  30. WIDATY S, Oktarina C, Suling PL, Niode NJ, et al
    Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia.
    Mycoses. 2022;65:323-330.
    PubMed     Abstract available


  31. TRAVE I, Cozzani E, Canepa P, Verdiani S, et al
    Real-life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis.
    Mycoses. 2022;65:317-322.
    PubMed     Abstract available


    February 2022
  32. VILLACORTA CARI E, Leedy N, Ribes JA, Soria J, et al
    Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients.
    Mycoses. 2022;65:239-246.
    PubMed     Abstract available


    January 2022
  33. WANG S, Song Y, Wan Z, Chen W, et al
    Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis.
    Mycoses. 2022;65:35-44.
    PubMed     Abstract available


  34. POESTER VR, Stevens DA, Basso RP, Munhoz LS, et al
    CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil.
    Mycoses. 2022;65:30-34.
    PubMed     Abstract available


  35. SHENOY MM, Rengasamy M, Dogra S, Kaur T, et al
    A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Mycoses. 2022;65:13-23.
    PubMed     Abstract available


    December 2021
  36. KHURANA A, Agarwal A, Singh A, Sardana K, et al
    Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Mycoses. 2021;64:1480-1488.
    PubMed     Abstract available


  37. LAROCHE L, Bourgeois N, Lachaud L, Rispail P, et al
    Epidemiological analysis of nail aspergillosis and non-dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France (1991-2019).
    Mycoses. 2021;64:1546-1553.
    PubMed     Abstract available


  38. GUARANA M, Nouer SA, Nucci M
    EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
    Mycoses. 2021;64:1542-1545.
    PubMed     Abstract available


  39. HE M, Zeng J, Mao Y, Zheng Y, et al
    Aetiological changes of tinea capitis in the Hubei area in 60 years: Focus on adult tinea capitis.
    Mycoses. 2021;64:1527-1534.
    PubMed     Abstract available


    November 2021
  40. RONG T, Li R, Ruojun W
    Dysbiosis of Skin Mycobiome in Atopic Dermatitis.
    Mycoses. 2021 Nov 24. doi: 10.1111/myc.13402.
    PubMed     Abstract available


  41. ELSNER K, Holstein J, Hilke FJ, Blumenstock G, et al
    Prevalence of Candida species in Psoriasis.
    Mycoses. 2021 Nov 17. doi: 10.1111/myc.13399.
    PubMed     Abstract available


  42. ZHANG W, Wu S, Wang X, Gao Y, et al
    Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis-A Six-year Retrospective Cohort Study.
    Mycoses. 2021;64:1422-1428.
    PubMed     Abstract available


  43. JHA K, Shaw D, Karim A, Narang T, et al
    Immunological response and clinical profile in patients with recurrent dermatophytosis.
    Mycoses. 2021;64:1429-1441.
    PubMed     Abstract available


  44. JAIN A, Dhamale S, Sardesai V
    Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India.
    Mycoses. 2021;64:1442-1447.
    PubMed     Abstract available


  45. SHAMSIZADEH F, Ansari S, Zarei Mahmoudabadi A, Hubka V, et al
    In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.
    Mycoses. 2021;64:1378-1386.
    PubMed     Abstract available


    October 2021
  46. SHARMA B, Nonzom S
    Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India.
    Mycoses. 2021 Oct 3. doi: 10.1111/myc.13378.
    PubMed     Abstract available


  47. NOWICKA D, Nawrot U
    Tinea pedis-An embarrassing problem for health and beauty-A narrative review.
    Mycoses. 2021;64:1140-1150.
    PubMed     Abstract available


  48. ZHAO Y, Gan M, Li L, Su H, et al
    Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence.
    Mycoses. 2021;64:1272-1278.
    PubMed     Abstract available


    September 2021
  49. BADIANE AS, Diongue K, Seck MC, Ndiaye M, et al
    Epidemiological aspects of superficial fungal infections in Koranic schools in two localities of Senegal (Thies and Touba).
    Mycoses. 2021;64:1132-1136.
    PubMed     Abstract available


    August 2021
  50. METIN MS, Elmas OF, Demirbas A, Erel O, et al
    The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis.
    Mycoses. 2021;64:947-953.
    PubMed     Abstract available


  51. GNAT S, Dylag M, Lagowski D, Zielinski J, et al
    Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
    Mycoses. 2021;64:967-975.
    PubMed     Abstract available


  52. SHAW D, Ghosh AK, Paul S, Singh S, et al
    Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes.
    Mycoses. 2021;64:926-935.
    PubMed     Abstract available


  53. SHARMA B, Nonzom S
    Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis.
    Mycoses. 2021;64:890-908.
    PubMed     Abstract available


  54. CHANG MJ, Qiu Y, Lipner SR
    Race reporting and representation in onychomycosis clinical trials: A systematic review.
    Mycoses. 2021;64:954-966.
    PubMed     Abstract available


    July 2021
  55. PHAM CVA, Rademacher F, Hinrichs H, Beck-Jendroschek V, et al
    Expression of epidermal antimicrobial peptides is increased in tinea pedis.
    Mycoses. 2021;64:763-770.
    PubMed     Abstract available


  56. DA COSTA B, Pippi B, Berlitz SJ, Carvalho AR, et al
    Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
    Mycoses. 2021;64:727-733.
    PubMed     Abstract available


  57. SINGH A, Singh P, Dingemans G, Meis JF, et al
    Evaluation of DermaGenius((R)) resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant Trichophyton species.
    Mycoses. 2021;64:721-726.
    PubMed     Abstract available


  58. ABDILLAH A, Packeu A, Khelaifia S, Ranque S, et al
    Intra- and inter-laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing.
    Mycoses. 2021;64:716-720.
    PubMed     Abstract available


  59. BADALI H, Canete-Gibas C, Patterson H, Sanders C, et al
    In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Mycoses. 2021;64:748-752.
    PubMed     Abstract available


  60. REINEL D
    Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice.
    Mycoses. 2021;64:694-700.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: